HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICCVAM Plans Next Steps Toward Reducing Animal Use In Toxicity Testing

This article was originally published in The Rose Sheet

Executive Summary

Two federal agencies charged with reducing, refining and replacing the use of animals in U.S. toxicology testing have released a draft plan that, beginning in 2008, will guide their efforts over the next five years

You may also be interested in...



NTP Touts 2010-2011 Achievements In Race To End Animal Testing

Interagency Groups under NIH’s National Toxicology Program contributed to the adoption of 14 new and updated test methods to refine, reduce and replace the use of animals, and continued making strides toward global harmonization, in 2010-2011. NICEATM and ICCVAM provide a progress report.

Robots Represent Future Of Toxicological Testing, Agencies Say

The National Institutes of Health and EPA are collaborating on a "high throughput" toxicology testing method that could replace animal assays with high-speed, automated screening robots, the agencies announced Feb. 14

Robots Represent Future Of Toxicological Testing, Agencies Say

The National Institutes of Health and EPA are collaborating on a "high throughput" toxicology testing method that could replace animal assays with high-speed, automated screening robots, the agencies announced Feb. 14

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014711

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel